Nantahala Capital Management »

Aileron Therapeutics shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Aileron Therapeutics (ALRN) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Aileron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aileron Therapeutics held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aileron Therapeutics by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $1.7M 255k 6.63

More positions owned by Nantahala Capital Management

Ishares Tr Russell 2000 Etf Put Option (IWM)
Spdr Ser Tr S&p Biotech (XBI)
Establishment Labs Holdings Ord (ESTA)
Soleno Therapeutics (SLNO)
Eli Lilly & Co. Put Option (LLY)
Grand Canyon Education Put Option (LOPE)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Evolus (EOLS)
Peloton Interactive Cl A Com (PTON)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)
Bioventus Com Cl A (BVS)
Rumbleon Com Cl B (RMBL)
Ishares Tr U.s. Real Es Etf Put Option (IYR)

View all positions for Nantahala Capital Management

Top funds holding Aileron Therapeutics

Satter Management
Nantahala Capital Management
Geode Capital Management
Sigma Planning
Vanguard Group
Gagnon Securities
Royal Bank of Canada
William Blair $ Company
Texas Capital Bank Wealth Management Services
Citadel Advisors
Tower Research Capital
JFS Wealth Advisors
Us Bancorp
Morgan Stanley
FMR

View all funds holding Aileron Therapeutics